Client News

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

Meliodays and Celanese Partner for Meliodays’ Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain

Abivax Announces Closing of $747.5 Million Public Offering

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

100 Patients Already Enrolled: ARTCLINE Reports Rapid Progress in Multicenter Clinical Study on Immune Support in Septic Shock (ReActIF-ICE)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

MIG Capital leads CHF 7.75 million seed financing for ASTRA Therapeutics

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris